Advertisement
A settlement of $775 million will be paid to settle lawsuits involving the blood thinner Xarelto

$775 Million Settlement Reached in Xarelto Lawsuits

0
Patients claim companies failed to warn about the risk for potentially fatal bleeding episodes
Statins reduce the rate of vascular events regardless of patient age

Statins Cut Risk for Major Vascular Events in Older Patients

0
Effects seen even among patients older than 75 years, though with less direct evidence of benefit
For euthyroid women with thyroid peroxidase antibodies and a history of miscarriage or infertility

ENDO: Levothyroxine Does Not Up Fertility in Women With TPO Ab

0
Live-birth rate did not increase for euthyroid women with thyroid peroxidase antibodies before conception
Recommendations have been developed for the management of diabetes in older adults; the clinical practice guideline was published online March 23 in the Journal of Clinical Endocrinology & Metabolism to coincide with the annual meeting of The Endocrine Society

ENDO: Guidance Provided for Managing Diabetes in Seniors

0
Simplified med regimens, tailored glycemic targets recommended for those with cognitive impairment
A short course of calcipotriol plus 5-fluorouracil treatment for actinic keratosis is associated with induction of robust T cell immunity and reduced development of squamous cell carcinoma within three years

Topical Immunotx for Actinic Keratosis May Prevent Cancer

0
Fewer patients treated with calcipotriol plus 5-FU developed SCC on treated face, scalp within three years
The current standard of care for advanced cervical cancer -- external beam radiation therapy and chemotherapy in combination with brachytherapy -- provides significantly higher overall survival over chemoradiation alone; however

Brachytherapy Boost Ups Survival in Locally Advanced Cervical Cancer

0
Findings observed regardless of treatment duration; disparities for brachytherapy use seen in vulnerable populations
The number of adults reporting the use of strategies

Many Patients Still Employ Strategies to Reduce Prescription Drug Costs

0
33.6 percent of patients reported not taking medication as prescribed to reduce costs
Women with recurrent ovarian cancer who receive the poly ADP ribose polymerase inhibitor niraparib as maintenance therapy after treatment have both more time without side effects and significantly longer progression-free survival than those on placebo

Niraparib Extends Time Without Symptoms in Ovarian Cancer

0
Findings based on phase 3 study of maintenance therapy with PARP inhibitor following treatment

American College of Cardiology, March 16-18

0
The American College of Cardiology's 68th Annual Scientific Session and Expo The annual meeting of the American College of Cardiology was held from...
Arguments against vaccination remain consistent within subgroups of individuals

Analysis IDs Messages Behind Antivaccination Comments

0
Four distinct subgroups of comments were identified: trust, alternatives, safety, and conspiracy